VideoViral Hepatitis and Liver DiseaseEliminating Hepatitis C by 2030 - Enhancing prevention care and treatment among people who inject drugs | Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhDView Video
VideoViral Hepatitis and Liver DiseaseStrategy for the Elimination of Hepatitis B and C (Academy of Medicine Report) | Andrew Aronsohn, MDView Video
VideoViral Hepatitis and Liver DiseaseThe French and European Approach Towards Hepatitis Elimination | Tarik Asselah, MD, PhDView Video
VideoViral Hepatitis and Liver DiseaseConsensus AASLD-EASL HBV Treatment Endpoint and HBV Cure Definition | Anna S. Lok, MD, DScView Video
VideoViral Hepatitis and Liver DiseaseGlobal Strategies to Eliminate Hepatitis B (ICE-HBV) | Peter RevillView Video
VideoViral Hepatitis and Liver DiseaseAccess to HIV, HBV, and HCV Antiviral Agents Globally | John Martin, PhDView Video
VideoViral Hepatitis and Liver DiseaseLiver Disease in Chinese-perspective from a Hepatologist | George Lau, MBBS, MRCP, FHKCP, FHKAM, MD, FRCPView Video
VideoViral Hepatitis and Liver DiseaseDAA Therapy and Reinfection Among People who Inject Drugs: Forming a Foundation for HCV Elimination | Jason GrebelyView Video
VideoViral Hepatitis and Liver DiseaseShort Duration DAA HCV Therapy: How Short Can We Go? | Shyam Kottilil, MD, PhDView Video
VideoViral Hepatitis and Liver DiseasePersonalized Approaches to HBV Cure | Marion Peters, MDView Video
VideoViral Hepatitis and Liver DiseaseIs Host Genome Integrated HBV Relevant? - The Con Perspective | Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)View Video
VideoViral Hepatitis and Liver DiseaseEndpoints and New Targets for Curing Hepatitis B | Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)View Video
VideoViral Hepatitis and Liver DiseaseCore Antibody: anti-HBc What is the Core of the Story? | Robert Gish, MDView Video
VideoViral Hepatitis and Liver DiseaseDevelopment of Immune Competent Small Animal Models for HBV | Helene Strick-MarchandView Video
VideoViral Hepatitis and Liver DiseaseSB 9200: A novel RIG-I agonist for chronic hepatitis B | Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)View Video
VideoViral Hepatitis and Liver DiseaseClinical Challenges in HCV infection | Mark Sulkowski, MDView Video
VideoViral Hepatitis and Liver DiseaseManagement of HCV in Decompensated liver disease | Michael MannsView Video
VideoViral Hepatitis and Liver DiseaseDAA Controversies: Do they Cause HBV Reactivation and/or HCC? | Jordan Feld, MD, MPHView Video
VideoViral Hepatitis and Liver DiseasePan-genotypic direct-acting antiviral agents: Opportunity to achieve HCV elimination | Tarik AsselahView Video
VideoViral Hepatitis and Liver DiseaseRevisiting the Molecular and Cell Biology of the Hepatitis B Virus Towards Elimination | Fabien Zoulim, MD, PhDView Video
VideoViral Hepatitis and Liver DiseaseHEV Update: Diagnostics and Management | Kenneth Sherman, MD, PhDView Video
VideoViral Hepatitis and Liver DiseaseLooking back to move forward: designing next-gen RNAi for best results in HBV | Bruce GivenView Video
VideoViral Hepatitis and Liver DiseaseNASH Globally: Pathways to Combination Therapy, Biomarkers and Outcomes | Arun SanyalView Video
VideoViral Hepatitis and Liver DiseaseThe Re-vival of Bile Acid Based Therapeutics for Children and Adults | Saul KarpenView Video
VideoViral Hepatitis and Liver DiseaseThe Effectiveness of Treatment for Chronic Hepatitis C (and Hepatitis B) in Pediatric Populations | Manal El-Sayed, MD, PhDView Video
VideoViral Hepatitis and Liver DiseaseAramchol for NASH and beyond: From scientific rationale to clinical development | Carol BrosgartView Video
